Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2025-12-30 @ 5:07 PM
Study NCT ID:
NCT03849469
Status:
COMPLETED
Last Update Posted:
2023-03-30
First Post:
2019-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Sponsor:
Xencor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-19
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-29
Last Update Post Date:
2023-03-30
Last Update Post Date Type:
ACTUAL